Skip to main content
. 2023 Feb 26;24(5):4580. doi: 10.3390/ijms24054580
ALK Anaplastic lymphoma kinase
CL-R clindamycin-resistance
CS Cigarette smoke
CT Computer Tomography
ECOG-PS The Eastern Cooperative Oncology Group performance status
EGFR epidermal growth factor receptor
ER-R erythromycin-resistant
EUCAST European Committee on Antimicrobial Susceptibility Testing
fnbA fibronectin binding protein A
GE-R gentamicin-resistance
irAEs immune-related adverse events
LMR Locus Minoris Resistentiae
NSCLC non-small cell lung cancer
PAH Polycyclic Aromatic Hydrocarbons
PD progressive disease
PD-1 Programmed death 1
PD-L1 Programmed death ligand-1